The cAMP-Dependent Protein Kinase, regulatory subunit RIIa reversibly inhibits the catalytic subunit Ca of the cAMP-dependent protein kinase PKA. The inhibition of the catalytic subunit can be reversed by the addition of the second messenger cAMP (>1uM).
Purity
>95% as determined by SDS-PAGE.
Product Form
Liquid
Concentration
Lot Specific
Formulation
Supplied in 20 mM MES Buffer with 150 mM Sodium Chloride, 2 mM EDTA, 2 mM EGTA, 1 mM beta-Mercaptoethanol, and 50% Glycerol.
Storage
Shipped at 4°C. Short term (2-4 weeks) store at 4°C. Long term store at -20°C. Avoid freeze/thaw cycles.
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Recombinant Human PKA R2/PKR2 Protein (A62070)? Please let us know so that we can list the citation on this page.
